TENX Latest Press Releases

-- December 17, 2025 --

Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment Globe Newswire 9:16 AM

-- November 25, 2025 --

Tenax Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

-- November 12, 2025 --

Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update Globe Newswire 4:05 PM

-- November 6, 2025 --

Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 (Oral Levosimendan) for the Treatment of PH-HFpEF Globe Newswire 7:00 AM

-- November 3, 2025 --

Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference Globe Newswire 7:00 AM

-- September 16, 2025 --

Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF Globe Newswire 7:00 AM

-- August 28, 2025 --

Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025 Globe Newswire 7:00 AM

-- August 13, 2025 --

Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software